How do you grade and treat Bell's palsy in an adult patient with no underlying medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Grading Bell's Palsy

Primary Grading System

The House-Brackmann (HB) grading system is the standard tool for assessing Bell's palsy severity, ranging from Grade 1 (normal function) to Grade 6 (complete paralysis). 1, 2

House-Brackmann Grading Scale

  • Grade 1: Normal facial function with no visible weakness or asymmetry 1
  • Grade 2: Slight weakness noticeable on close inspection; complete eye closure with minimal effort; slight asymmetry of smile with maximal effort 1
  • Grade 3: Obvious but not disfiguring asymmetry; noticeable difference between sides; slight to no forehead movement; incomplete eye closure; obvious asymmetry with mouth movement 1
  • Grade 4: Obvious disfiguring weakness; inability to close eye completely even with maximal effort; severe asymmetry of mouth with movement 1
  • Grade 5: Only barely perceptible motion; visible asymmetry at rest with drooping mouth corner and decreased/absent nasolabial fold; incomplete eye closure with only slight lid movement 1
  • Grade 6: Complete paralysis with no movement whatsoever; total loss of facial tone with marked asymmetry 1

Alternative Grading Systems

While HB remains the standard, two other validated systems exist:

  • Sunnybrook Facial Grading System (SFGS): Shows moderate correlation with HB (r = -0.876); a score ≤68 indicates severe palsy requiring aggressive management 3
  • Modified Portmann Scale (MPS): Also demonstrates moderate correlation with HB (r = -0.860); a score ≤16 indicates severe dysfunction 3

The HB system is preferred for clinical practice because it is universally recognized and facilitates communication between specialists. 1, 2

Critical Assessment Components

Forehead Function

  • Forehead involvement distinguishes Bell's palsy from stroke - inability to wrinkle forehead on affected side confirms peripheral (Bell's palsy) rather than central (stroke) pathology 1
  • Test by asking patient to raise eyebrows and look for asymmetry 2

Eye Closure Assessment

  • Evaluate ability to close eye completely with gentle and maximal effort 1, 2
  • Incomplete eye closure (lagophthalmos) requires immediate eye protection measures regardless of HB grade 1, 2
  • Note: The numeric HB grade alone is insufficient for predicting corneal risk - direct measurement of lagophthalmos is more reliable 4

Mouth Movement

  • Assess symmetry when smiling, showing teeth, and puffing out cheeks 2
  • Observe for drooping of mouth corner and loss of nasolabial fold at rest 1

Additional Features to Document

  • Taste disturbance on anterior two-thirds of tongue (chorda tympani involvement) 1, 2
  • Hyperacusis (increased sound sensitivity from stapedius muscle paralysis) 1, 2
  • Dry eye or mouth from autonomic fiber involvement 1, 2
  • Ipsilateral ear or facial pain (common presenting symptom) 1

Prognostic Implications by Grade

Favorable Prognosis (Grades 1-3)

  • Incomplete paralysis predicts up to 94% complete recovery 2, 5
  • Most patients begin recovery within 2-3 weeks 2
  • Complete recovery typically occurs within 3-4 months 2

Guarded Prognosis (Grades 4-6)

  • Complete paralysis carries approximately 70% complete recovery rate 2, 5
  • 30% risk of permanent facial weakness with muscle contractures 1, 2
  • Consider electrodiagnostic testing (ENoG/EMG) at 3-14 days post-onset for prognostic information 2
  • ENoG showing <10% nerve response amplitude compared to unaffected side indicates up to 50% risk of incomplete recovery 2

Treatment Algorithm Based on Grade

All Grades (Within 72 Hours of Onset)

Prescribe oral corticosteroids immediately: prednisolone 50 mg daily for 10 days OR prednisone 60 mg daily for 5 days followed by 5-day taper 1, 2

  • Evidence shows 83% recovery at 3 months with steroids vs 63.6% with placebo 1, 2
  • Treatment beyond 72 hours shows no proven benefit 2

Optional Addition for All Grades

  • Consider adding antiviral therapy (valacyclovir 1g three times daily for 7 days OR acyclovir 400mg five times daily for 10 days) to steroids 2, 5
  • Combination therapy shows 96.5% complete recovery vs 89.7% with steroids alone, though benefit is small 1
  • Never prescribe antivirals alone - they are ineffective as monotherapy 1, 2

Eye Protection (Grades 3-6 with Incomplete Eye Closure)

Implement immediately to prevent permanent corneal damage: 1, 2

  • Lubricating drops every 1-2 hours while awake 2
  • Ophthalmic ointment at bedtime 2
  • Eye taping or patching at night (with careful instruction to avoid corneal abrasion) 1, 2
  • Sunglasses outdoors 1, 2
  • Urgent ophthalmology referral for complete inability to close eye 2

Electrodiagnostic Testing (Grade 6 Only)

  • Offer ENoG/EMG to patients with complete paralysis 2
  • Perform between 3-14 days post-onset for reliable prognostic information 2, 6
  • Testing before 7 days or after 14-21 days may be unreliable due to ongoing Wallerian degeneration 2

Mandatory Reassessment Triggers

Refer to facial nerve specialist or reassess immediately if: 1, 2

  • Incomplete facial recovery at 3 months post-onset 1, 2
  • New or worsening neurologic findings at any point 1, 2
  • Development of ocular symptoms at any point 1, 2
  • Progressive weakness beyond 3 weeks (suggests alternative diagnosis) 2

Critical Pitfalls to Avoid

  • Failing to test forehead function leads to missed stroke diagnosis - central facial weakness spares the forehead 1
  • Relying solely on HB grade for eye protection decisions - directly measure lagophthalmos and upper lid closure instead 4
  • Delaying corticosteroid treatment beyond 72 hours - effectiveness drops significantly 1, 2
  • Prescribing antivirals alone - completely ineffective without steroids 1, 2
  • Missing bilateral involvement - extremely rare in Bell's palsy and should trigger investigation for Lyme disease, sarcoidosis, or Guillain-Barré syndrome 1, 7
  • Accepting recurrent episodes as "Bell's palsy" - recurrence requires imaging and workup for underlying etiology (tumor, sarcoidosis, Lyme disease, diabetes) 7

References

Guideline

Diagnostic Criteria and Exclusions for Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Assessment and Management of Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Bell Palsy: Rapid Evidence Review.

American family physician, 2023

Guideline

Etiology and Management of Recurrent Bell's Palsy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the role of the House-Brackmann score in evaluating and managing a patient with Bell's palsy?
What is the Bell's palsy score and how is it used to assess and treat a patient with Bell's palsy?
Is acyclovir (antiviral medication) recommended for treatment of Bell's palsy of 1 week duration?
What are the next steps for an 11-year-old patient with Bell's palsy, currently on prednisone and valacyclovir (antiviral), who is experiencing worsening tingling on the right side of their face 5 days after diagnosis?
What is the initial treatment for a female patient with Bell's Palsy?
What is the management and treatment approach for a patient with suspected Hermansky-Pudlak syndrome?
What is the recommended initial dose of insulin for a pregnant woman with Gestational Diabetes Mellitus (GDM)?
What is the best course of treatment for a patient with improving necrotizing fasciitis of the abdominal wall, persistent fever, and a history of urinary catheter (UC) use, considering potential urinary tract infection (UTI) or fungemia, and possible underlying conditions such as diabetes or immunosuppression?
What is the most suitable action for health promotion and illness prevention in a pregnant patient with a history of multiple sexually transmitted diseases (STDs), presenting at 37 weeks gestation, to prevent conjunctivitis and blindness in the newborn?
What are the potential interactions and side effects of combining sorbitol and amino acids (AAs) in patients, particularly those with impaired renal function or diabetes?
What is the difference between drotaverine and dicyclomine (anticholinergic agent) for a patient with irritable bowel syndrome (IBS) and no significant contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.